Xin Nakanishi, Ph.D. has served as a member of Oncternal’s board of directors since November 2018. She has served as the Chief Executive Officer of Shanghai Pharma Biotherapeutics USA Inc since July 2018. Dr. Nakanishi previously served as a venture partner at Yuansheng bioVENTURE from 2017-2018, and was CEO and founder of Sunvita Therapeutics, LLC from 2009- 2018 a company that provided cross border business development for various US and Chinese biopharmaceutical companies. She was also the Director of Biology at Phenomix Inc, a senior scientist at Pfizer, and a group leader at Immusol Inc. Dr. Nakanishi holds a B.A. in Virology from Wuhan University and a Ph.D in Biochemistry from the University of Kansas.